TGFB1 and pulmonary fibrosis: Current therapies for pulmonary fibrosis target TGF-β1 signaling in order to prevent fibroblast dysregulation (King et al., 2014; Xaubet et al., 2014; Myllarniemi and Kaarteenaho, 2015).